2015 Q3/Global Life Sciences


Summary

Full results


Changes in rank are compared to 2015 Q2/Global Life Sciences. Since then, 9 sites entered the survey, 4 sites left the survey and 41 sites could not be included in the rankings (7 fewer since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
+ 4 Anika Therapeutics 7.84
new Neurocrine Biosciences 7.58
+ 10 Wockhardt 7.38
- 3 Actelion 7.20
- 1 Kyorin Holdings 7.04
+ 3 Taisho Pharmaceutical 6.98
+ 11 Yakult UK 6.93
- 6 Otsuka Pharmaceuticals Europe 6.91
- 6 Nissan Chemical 6.82
- 4 Kaken Pharmaceutical 6.74
- 4 ProStrakan Group 6.39
- 4 Meda Pharmaceuticals 6.39
+ 10 Mitsubishi Tanabe Pharma Europe Ltd 6.32
- 4 Galenica AG 6.21
same Diffusion Pharmaceuticals 6.07
- 2 Bavarian Nordic 5.96
+ 10 Debiopharm 5.87
+ 11 Dainippon Sumitomo 5.86
+ 9 Zandu 5.76
- 8 Lundbeck 5.72
+ 13 Forest 5.61
- 3 Medivation 5.47
- 2 EISAI 5.42
+ 32 Alfa Wassermann 5.36
+ 23 Pfizer UK 5.33
- 4 EISAI UK 5.33
- 10 Servier 5.21
+ 35 Astellas Europe 5.20
- 4 United Therapeutics 5.19
- 4 Santen 5.16
new Takeda UK 5.12
- 2 Gruenenthal 5.10
- 22 Ipsen UK 5.08
- 14 Recordati 5.07
+ 8 Enzo Biochem 5.03
+ 31 Genmab 5.02
+ 12 Stallergenes UK 4.97
+ 150 Dr Reddy's 4.97
- 15 CinnaGen 4.95
+ 4 Covence 4.92
- 10 Towa Pharmaceutical 4.91
- 9 Astrazeneca Uk 4.89
- 8 Valeant Europe 4.89
+ 16 Acorda Therapeutics 4.88
+ 27 BTG International 4.88
- 10 Daiichi-Sankyo UK 4.87
+ 5 Shire 4.86
+ 10 Stallergenes 4.86
- 9 Agennix 4.84
- 9 MediGene 4.84
+ 15 Biotest 4.84
- 10 Galderma 4.78
+ 22 GlaxoSmithKline 4.78
+ 1 Mochida 4.76
- 10 Laboratoires Thea 4.74
- 10 Servier UK 4.73
- 25 Genzyme UK 4.72
- 11 Aptalis Pharma 4.71
- 8 Otsuka Pharmaceuticals 4.69
+ 17 Roche 4.68
- 23 Boehringer Ingelheim 4.68
- 46 Nippon Chemiphar 4.68
+ 6 Abbott 4.66
- 10 Laboratoires Thea UK 4.60
- 26 Sanofi UK 4.58
new Teijin Europe 4.52
+ 16 Apotex 4.50
+ 10 Menarini UK 4.48
+ 109 Actavis 4.48
- 6 Astrazeneca 4.48
- 14 Abbott Uk 4.46
+ 20 Lilly UK 4.42
+ 8 Boehringer Ingelheim UK 4.41
- 6 Galapagos 4.40
- 5 KRKA 4.40
+ 3 Pierre Fabre 4.38
- 27 Sawai Pharmaceutical 4.34
- 17 Valeant Pharmaceuticals 4.33
+ 6 Meiji Holdings 4.32
+ 40 Menarini 4.30
+ 21 Avanir Pharmaceuticals 4.28
- 29 Hikma Pharmaceuticals 4.24
+ 60 Allergan 4.22
- 19 Mitsubishi Tanabe 4.22
+ 50 Leo Pharma 4.19
- 27 Nippon Kayaku 4.16
+ 46 Torrent Pharmacueticals 4.15
- 26 Onyx Pharmaceuticals 4.14
- 5 Astellas 4.14
+ 1 Merz 4.12
new Alcon UK 4.12
- 4 Perrigo 4.12
- 4 Elan 4.12
+ 14 Bayer UK & Ireland 4.10
+ 32 Exelixis 4.07
+ 53 Pharmstandard 4.05
+ 9 Stada 4.04
new Intas Pharmaceuticals 4.04
+ 22 Vitrolife 4.02
- 29 Novartis UK 4.02
- 64 Kissei 3.98
+ 88 Bosnalijek 3.97
- 6 Daiichi-Sankyo 3.96
- 9 Bayer Schering Pharma 3.96
- 7 Ferozsons Laboratories 3.94
- 6 CSL Behring 3.94
- 6 Gilead Sciences 3.92
- 5 Impax Laboratories 3.91
- 19 Bial Portela 3.90
- 28 QLT 3.89
+ 17 Toray Industries 3.87
- 36 PDL BioPharma 3.87
- 8 Cerus 3.87
- 27 Alcon 3.86
- 8 ImmunoGen 3.86
- 1 Vertex Pharmaceuticals 3.80
+ 8 Asahi Kasei 3.80
- 24 Square Pharmaceuticals 3.79
+ 17 Leo Pharma UK 3.79
- 9 Regeneron 3.78
- 9 Jazz Pharmaceuticals 3.77
- 13 Kyowa Hakko Kirin 3.73
- 9 The Medicines Co 3.73
- 8 Auxilium Pharmaceuticals 3.72
- 7 Hutchison China MediTech 3.70
+ 19 Targacept 3.70
- 8 Orion Pharma 3.70
- 29 Seattle Genetics 3.68
- 33 Julphar 3.63
- 6 Piramel Enterprises 3.63
+ 23 Endo Pharmaceuticals 3.62
- 52 Ipsen 3.61
- 4 Array BioPharma 3.60
- 4 Fresenius Medical Care 3.58
- 3 Allergan UK 3.55
+ 2 Biotecnol 3.52
- 3 Nova Nordisk UK 3.52
+ 1 Senju Pharmaceutical 3.52
+ 1 Melior Discovery 3.50
+ 2 China Pharmaceutical Group 3.49
+ 3 Roche UK 3.48
- 19 Johnson & Johnson 3.46
- 33 Nektar Therapeutics 3.43
+ 2 Yakult Honsha 3.42
+ 15 Nova Nordisk 3.40
+ 1 ARIAD Pharmaceuticals 3.40
+ 60 Arena Pharmaceuticals 3.35
+ 14 MorphoSys 3.33
- 18 UCB Belgium 3.32
- 13 Johnson & Johnson UK 3.27
+ 4 BioMarin Pharmaceutical 3.25
+ 4 SOBI 3.23
- 67 Advaxis 3.23
+ 19 MannKind Corporation 3.22
+ 8 Orchid Pharmaceuticals 3.22
- 3 Italfaraco 3.17
- 64 Akorn 3.16
- 36 Novartis 3.15
+ 16 Alexion Pharmaceuticals 3.14
- 19 Baxter Healthcare UK 3.14
same Genus 3.13
+ 10 ALK-Abello 3.13
- 50 Eskayef Bangladesh Ltd 3.11
- 60 Pharma Nord 3.09
- 48 Pharmacosmos 3.08
new Celgene UK 3.07
+ 3 Isis Pharmaceuticals 3.07
+ 8 Covidien 3.00
+ 60 Mylan 2.98
+ 1 Takeda 2.98
- 6 Teva Pharmaceutical Industries Ltd 2.96
- 6 Laboratorios Farmaceuticos ROVI 2.96
+ 7 Purdue Pharma 2.96
- 7 SciClone Pharmaceuticals 2.95
- 6 Lilly 2.89
+ 8 Paladin Labs 2.83
- 3 Genzyme 2.80
- 19 Celgene 2.78
- 28 Biogen Idec 2.78
- 3 Handok 2.73
- 2 AEterna Zentaris 2.71
- 32 Elder Pharmaceuticals 2.71
+ 14 Lupin Pharmaceuticals 2.71
- 2 Panacea Biotec 2.68
+ 16 Alkaloid 2.68
- 28 Zambon 2.61
same Sanofi 2.58
- 20 Anavex Life Sciences Corp 2.55
+ 27 Bionovo 2.55
+ 1 Salix 2.52
+ 1 Maruho 2.52
new Emergent BioSolutions 2.51
same Chiesi 2.51
same Ligand Pharmaceuticals 2.51
- 12 Sigma-Tau 2.50
- 48 Biocon 2.50
- 2 Strides Arcolab 2.49
- 34 Esteve 2.48
+ 25 Baxter International 2.47
- 4 Getz Pharma 2.45
+ 11 Idenix Pharmaceuticals 2.45
- 4 Zentiva 2.45
- 46 Maxygen 2.43
- 5 Medivir Group 2.43
- 5 Unilab 2.43
- 21 Sun Pharmaceuticals 2.43
- 4 Seikagaku 2.38
- 3 Chugai - Pharma 2.36
- 3 Hisamitsu 2.34
- 2 Lavipharm 2.33
- 2 UCB 2.32
- 1 Cipla 2.32
new Glenmark Pharmaceuticals Europe 2.30
- 25 Taro Pharmaceutical Industries 2.29
- 1 Patheon 2.24
+ 2 Kaneka 2.17
new Biota 2.17
- 37 Ferring 2.16
- 4 Xoma 2.16
- 18 Amgen UK 2.15
- 17 Incepta Pharmaceuticals 2.12
- 12 Bristol-Myers Squibb 2.06
+ 11 Bristol-Myers Squibb UK 2.06
+ 2 Simcere Pharmaceutical 2.03
+ 2 Gedeon Richter 1.99
+ 2 Aspen Pharmacare 1.99
- 75 Progenics Pharmaceuticals 1.94
- 9 Myriad Genetics 1.90
- 9 Almirall Spain 1.89
- 9 Veloxis Pharmaceuticals 1.84
- 9 Nippon Shinyaku 1.84
+ 1 Merz UK 1.83
- 10 Pfizer 1.81
- 4 Alphapharm 1.75
- 18 Par Pharmaceutical Companies 1.67
- 1 Perrigo UK 1.62
- 6 Faes Farma 1.62
same Ego Pharmaceuticals 1.38
- 2 Hospira UK 1.37
- 4 Enzon Pharmaceuticals 1.29
- 28 Santen Europe 1.21
- 3 Hospira 1.11
- 2 Sinopharm 0.59
- 12 Beximco Pharmaceuticals 0.58